Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts?

Xenotransplantation

Volumn 10, Issue 1, 2003, Pages 16-23

  Dorling, A ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute vascular rejection; Antibody; Endothelial activation; Xenoreactive antibodies; Xenotransplantation

Indexed keywords

CELL ANTIBODY; ENDOTHELIUM ANTIBODY; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; HETEROPHILE ANTIBODY;

ACUTE VASCULAR REJECTION; ANTIGEN ANTIBODY COMPLEX; CELL HETEROGENEITY; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DISEASE CLASSIFICATION; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY CELL; MACROPHAGE; MEDICAL RESEARCH; NATURAL KILLER CELL; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; XENOGRAFT; ACUTE DISEASE; ANIMAL; IMMUNOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANIMALS; ANTIBODIES, HETEROPHILE; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0037997349     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.01134.x     Document Type: Conference Paper

References (53)

1. PRUITT SK, KIRK AD, BOLLINGER RR et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
2. VAN DEN BOGAERDE J, ASPINALL R, WANG M-W et al. Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991; 52: 15.
3. COZZI E, WHITE DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
4. SOIN B, VIAL CM, MASROOR S et al. Peri-operative TP10 (sCR1) improves early graft function and in combination with RAD and neoral extends survival after prolonged cold ischaemia in hDAF-transgenic pig to primate renal xenotransplantation. Transplantation 2000; 69: S252.
5. HECKER JM, LORENZ R, APPIAH R et al. C1-inhibitor (C1-INH) for treatment of acute vascular xcnograft rejection (AVR) in cynomolgus recipients of porcine kidneys. Am J Transplant 2001; 1 (Suppl. 1): 153.
6. WATERWORTH PD, DUNNING J, TOLAN M et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17: 1201.
7. LOSS M, VANGEROW B, SCHMIDTKO J et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7: 186.
8. LEVENTHAL JR, MATAS AJ, SUN LH et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
9. LEVENTHAL JR, DALMASSO AP, CRANWELL JW et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
10. SCHERINGA M, SCHRAA EO, BOUWMAN E et al. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. Transplantation 1995; 60: 1350.
11. PLATT JL, LINDMAN BJ, GELLER RL et al. The role of natural antibodies in the activation of xenogeneic endothelial cells. Transplantation 1991; 52: 1037.
12. VANHOVE B, DE MARTIN R, LIPP J, BACH FH. Human xenoreactive natural antibodies of the IgM isotype activatc pig endothelial cells. Xenotransplantation 1994; 1: 17.
13. PALMETSHOFER A, GALILI U, DALMASSO AP, ROBSON SC, BACH FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation 1998; 65: 971.
14. PALMEXSHOFER A, GALILI U, DALMASSO AP, ROBSON SC, BACH FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. Transplantation 1998; 65: 844.
15. PALMETSHOFER A, ROBSON SC, BACH FH. Tyrosine phosphorylation following lectin mediated endothelial cell stimulation. Xenotransplantation 1998; 5: 61.
16. NASU K, WHYTE A, GREEN SJ, EVANS PC, KILSHAW PJ. Alpha-galactosyl-mediated activation of porcine endothelial cells: studies on CD31 and VE-cadherin in adhesion and signaling. Transplantation 1999; 68: 861.
17. MARUYAMA S, CANTU E, PERNIS B et al. Alpha-galactosyl antibody redistributes alpha-galactosyl at the surface of pig blood and endothelial cells. Transpl Immunol 1999; 7: 101.
18. BOULDAY G, COUPEL S, COULON F, SOULILLOU JP, CHARREAU B. Antigraft antibody-mediated expression of metalloproteinases on endothelial cells. Differential expression of TIMP-1 and ADAM-10 depends on antibody specificity and isotype. Circ Res 2001; 88: 430.
19. BACH FH, ROBSON SC, FERRAN C et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
20. BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
21. PLATT JL, VERCELLOTTI GM, DALMASSO AP et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
22. SOARES MP, LIN Y, SATO K, STUHLMEIER KM, BACH FH. Accommodation. Immunol Today 1999; 20: 434.
23. BACH FH, FERRAN C, HECHENLEITNER P et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196.
24. DALMASSO AP, HE T, BENSON BA. Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 1996; 3: 54.
25. DORLING A, STOCKER C, TSAO T, HASKARD DO, LECHLER RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996; 62: 1127.
26. DORLING A, LECHLER RI. Glaxo/MRS, Young Investigator Prize. Xenotransplantation: immune barriers beyond hyperacute rejection. Clin Sci Colch 1997; 93: 493.
27. HASAN R, VAN DEN BOGAERDE J, FORTY J et al. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. Transplant Proc 1992; 24: 531.
28. HASAN RIR, SRIWATANAWANGOSA V, WALLWORK J, WHITE DJG. Graft adaptation in hamster-to-rat cardiac xenografts. Transplant Proc 1994; 23: 1282.
29. BACH FH, TURMAN MA, VERCELLOTTI GM, PLATT JL, DALMASSO AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205.
30. DORLING A, DELIKOURAS A, NOHADANI AM, POLAK J, LECHLER RI. In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. Xenotransplantation 1998; 5: 84.
31. DALMASSO AP, BENSON BA, JOHNSON JS, LANCTO C, ABRAHAMSEN MS. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha (1) Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000; 164: 3764.
32. DELIKOURAS A, HAYES M, MALDE P, LECHLER RI, DORLING A. Nitric oxide-mediated expression of Bcl-2 and Bcl-x1 and protection from TNFa-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 2001; 71: 599.
33. DALMASSO AP. Understanding and achieving accommodation. Grati 2001; 4: 53.
34. EVANS PC, KILSHAW PJ. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1. Transplantation 2000; 70: 928.
35. HANCOCK WW, BUELOW R, SAYEGH MH, TURKA LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392.
36. DORLING A, JORDAN W, BROOKES P, DELIKOURAS A, LECHLER RI. 'Accommodated' pig endothelial cells promote nitric oxide-dependent Th-2 cytokine responses from human T cells. Transplantation 2001; 72: 1597-1602.
37. XU H, EDWARDS NM, CHEN JM et al. Newborn baboon serum lacks natural anti-pig xenoantibody. Transplantation 1995; 59: 1189.
38. KAPLON RJ, MICHLER RE, Xu H et al. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1995; 59: 1.
39. MINANOV OP, ITESCU S, NEETHLING FA et al. Anti-GaL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation 1997; 63: 182.
40. ITESCU S, KWIATKOWSKI P, ARTRIP JH et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275.
41. MINANOV OP, ARTRIP JH, SZABOLCS M et al. Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation. J Thorac Cardiovasc Surg 1998; 115: 998.
42. XIA G, JI P, RUTGEERTS O, WAER M. Natural killer cell- and macrophage-mediated discordant guinea pig-rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity. Transplantation 2000; 70: 86.
43. SIEGEL JB, GREY ST, LESNIKOSKI BA et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997; 64: 888.
44. ROBSON SC, COOPER DK, D'APICE AJ. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166.
45. ROSE AG, COOPER DK. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000; 7: 31.
46. COWAN PJ, CHEN CG, SHINKEL TA et al. Knock out of alpha 1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 1599.
47. COWAN PJ, AMINIA A, BARLOW H et al. Renal xenografts from triple transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504.
48. LIN SS, WEIDNER BC, BYRNE GW et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
49. CHEN RH, NAFICY S, LOGAN JS, DIAMOND LE, ADAMS DH. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6: 194.
50. BLAKELY ML, VAN DER WERF WJ, BERNDT MC et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
51. Xu H, GUNDRY SR, HANCOCK WW et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg 1998; 115: 1342.
52. SHIMIZU A, MEEHAN SM, KOZLOWSKI T et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000; 80: 815.
53. LIN SS, HANAWAY MJ, GONZALEZ SG et al. The role of anti-Galalpha1Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667.